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Abstract 
 
Treatment compliance for patients with chronic 
health problems is important for the management of 
their illness due to the long-term nature of their 
conditions. In this study, we examine how evaluations 
of different types of treatments provided by members of 
an online health community are associated with 
treatment evaluations and compliance. We use self-
reported data on evaluation and compliance of over 
270 different treatments from over 20,000 patients in a 
prominent online health community.  We find that other 
community members’ treatment evaluation valence is 
positively associated with patient treatment evaluation 
and treatment compliance. Similarly, other community 
members’ treatment compliance is positively 
associated with patient treatment compliance. We also 
find these relations are moderated by community size 
and ratings variance. We discuss the theoretical 
implications of these results for the online health 
communities’ literature, as well as the practical 
implications for patients, healthcare providers, and 
policy makers.  
 
 
1. Introduction  
 
The Internet is changing how people learn about 
and cope with chronic illness. Chronic diseases 
account for 86% of total healthcare costs and are the 
leading cause of death and disability in the United 
States [1]. Chronic diseases involve a recurring 
condition, usually associated with other health 
complications, impairment and disability [2]. Given the 
increase in popularity of Web 2.0. technologies, many 
patients with chronic health problems participate in 
online health communities for informational and social 
support [3]. Participation in online health communities 
enables patients to become not only consumers but also 
producers of health-related information. In these 
communities, patients share information about their 
experience with the illness such as their symptoms, 
their treatments, and how the illness affects their 
quality of life. Despite advances in Web 2.0. 
technologies, treatment compliance remains one of the 
main challenges for both doctors and patients of 
chronic health conditions. Research shows that 
approximately 50% of patients do not take medications 
as prescribed [4] and treatment noncompliance is 
associated with illness relapse and increased healthcare 
costs [5].  
The Health Belief Model (HBM) is one of the first 
models to explain how individuals make health-related 
decisions [6]. Accordingly, factors that affect 
compliance include patients’ beliefs about the 
treatment, risks and benefits associated with the 
treatment, and barriers to the treatment [5], [6]. The 
literature on compliance has shown that compliance is 
lower in the presence of side effects, long treatment 
periods, complex treatment regimens and mental health 
disorders [7]. Research has further shown that 
treatment beliefs are more powerful predictors to 
treatment compliance than clinical or 
sociodemographic factors [8].  
Past research has examined the influence of social 
media in shaping consumer behavior. For example, 
online ratings affect users’ consumption of different 
types of products and services, e.g., books [9], movies 
[10] and restaurants [11]. However, online ratings for 
credence goods—goods whose quality is difficult to 
assess even after use (e.g., treatments) [12]—have not 
received much attention. Some studies have provided 
empirical evidence on the importance of offline family 
and social support on treatment compliance [13]. 
However, it is not clear how patients make treatment 
decisions in the presence of Web 2.0. technologies that 
allow patients to connect with others, and obtain word 
of mouth regarding these treatments. 
In this study, we examine how patients’ post-
adoption treatment evaluation and treatment 
compliance are related with community members’ 
ratings about the treatment. Participating in an online 
health community may help patients discover new 
Proceedings of the 52nd Hawaii International Conference on System Sciences | 2019
URI: https://hdl.handle.net/10125/59825
ISBN: 978-0-9981331-2-6
(CC BY-NC-ND 4.0) Page 3888
treatments from other patients with similar conditions. 
The online community may also exert social influence 
over the patient’s perception of a treatment. Previous 
studies have found evidence of social influence even 
when people are not aware of it [14]. However, the 
effects of other online community members’ opinions 
on one’s perception about a treatment are not 
straightforward. Moreover, the extent to which patients 
are connected with other community members might 
also affect their perceptions about the treatment.  
With this motivation, we address the following 
research questions: 
1. How do online community members’ 
treatment evaluation affect patients’ treatment 
evaluation and compliance? 
2. How does community size and variance 
moderate the effect of community members’ treatment 
evaluation on patients’ treatment compliance? 
To answer the research questions, we analyze data 
from a popular online health community. We examine 
how treatment ratings in an online health community 
are associated with patients’ evaluation of a treatment 
for a wide range of treatments evaluated by patients 
with chronic healthcare problems. We find that online 
community members’ ratings of a treatment are 
positively associated with a focal patient’s evaluation 
of a treatment. We also find that other community 
members’ compliance is positively associated with a 
patient’s treatment compliance. These relationships are 
moderated by community size and ratings variance.  
The results of this study contribute to the literature 
on online communities by offering empirical evidence 
of the effects of community participation in a 
healthcare context. The study also contributes to the 
emerging literature on online health communities by 
focusing on the effects of digital cues provided by 
other community members on patients’ compliance 
with treatment in the case of chronic illnesses. Finally, 
the results of this study also have practical implications 
for patients and healthcare providers. 
The paper is organized as follows: In the next 
section, we provide a brief overview of two streams of 
related literature: online word of mouth and online 
health communities. We continue with a description of 
the research model and proposed hypotheses. Next, we 
describe the research method and empirical estimation 
on data from an online health community. Finally, we 
discuss the theoretical and managerial implications and 
conclude with limitations, and directions for future 
research 
 
 
 
 
2. Literature Review 
 
2.1. Online Word-of-Mouth 
  
Online reviews are a representation of user-
generated content and consumer word of mouth. 
Scholars have long investigated consumer motivations 
for word of mouth (WOM). A classic study [15] found 
consumers can be motivated by a strong feeling about a 
product (product-involvement), a desire to gratify 
certain emotional needs (self-involvement), a wish to 
help other consumers (other-involvement) or by 
advertisements or other communications (message-
involvement). Research has also examined the specific 
motivations behind posting online reviews [16], [17]. 
Reviewers seek both notoriety, as they are more likely 
to review lesser-known products, and community, as 
they are also more likely to review products that are 
more popular, and that have already received a large 
number of reviews [16].  
Online reviews are considered an important source 
of information for consumer decision-making [9], [18], 
[19]. Research on online reviews has shown that 
diagnostic reviews written by credible reviewers are 
helpful for consumers [20]. The perceived helpfulness 
of an online review is affected by review length, 
emotion, and rating [18], [21]. A large body of work in 
this area has examined the relationship between online 
reviews and sales. Previous studies have shown that the 
volume and valence of online reviews significantly 
impact sales of various products [9], [22]–[24]. Other 
studies have also looked at the impact of affective 
content of the reviews on conversion rates [25]. Studies 
have shown that review ratings negatively affect hotel 
bookings [26] and variance in brand ratings is 
significantly associated with firm value [27]. Studies 
have also examined multiple mediating factors for the 
relationship between word of mouth and sales 
including product type and consumer attributes [17].  
 
2.2. Online Health Communities 
 
A growing research stream is examining the impact 
of social networks on patients’ health outcomes. 
Previous studies on online health communities have 
argued that patients seek both informational support 
and social support in these communities [3]. Patients 
are willing to share personal health information in 
online health communities because they receive 
personal benefits such as create new social ties and 
obtain knowledge despite their privacy concerns [28]. 
Patients’ social connections in online health 
communities are affected by their health-related traits 
as people tend to find similar others to establish 
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connections [29]. Many studies on online health 
communities are limited to small communities focused 
only on one type of disease, for example, a community 
for patients with Parkinson’s disease [30] and a 
community for diabetes patients [31]. Studies have 
documented that an individual’s health is connected to 
the health of other socially connected individuals [32]. 
 
3. Hypotheses  
 
Based on a rich body of literature regarding 
compliance in healthcare and online ratings we argue 
how online community ratings are associated with 
patient treatment evaluation and compliance. There 
have been two main perspectives in the healthcare 
literature that explain patience compliance behavior. 
The first perspective focuses on the patient-doctor 
relationship and argues that compliance is higher when 
doctors give clear instructions on the treatment 
regimen [33]. The second perspective focuses on the 
patient, and stipulates that a patient’s beliefs about the 
treatment will affect compliance [34]. In this study, we 
adopt the second perspective, which emphasizes the 
importance of patients’ beliefs and perceptions about 
the treatment in explaining compliance. 
 
3.1. The Health Belief Model 
 
The Health Belief Model (HBM) provides one the 
main frameworks that relate patients’ beliefs with 
health-related behavior [34].  The original HBM was 
concerned with preventive health behaviors in the 
absence of symptoms. According to the Health 
Behavior Model, patients conduct a risk-benefit 
analysis before making health-related decisions. 
Patients evaluate the susceptibility to the disease, 
perceived threats and perceived benefits of preventive 
actions before taking the recommended preventive 
health action [34].  
Patients’ beliefs about their treatment are related to 
compliance behavior for chronic illness. According to 
the Theory of Reasoned Action, individuals’ decisions 
to engage in a behavior will depend on their pre-
existing attitudes and behavioral intentions [35]. 
Therefore, patients’ beliefs about the effectiveness of a 
treatment will be positively associated with their 
compliance behavior. Expanding on the HBM, which 
mainly focused on acute conditions, studies have 
linked patients’ beliefs about their treatment to 
compliance behavior for chronic illnesses. 
Accordingly, patient beliefs about the necessity of their 
treatment are positively related with compliance, while 
concerns about their treatment are negatively related 
with compliance [8]. Therefore, we expect the overall 
relationship between patient evaluation and compliance 
to be positive. 
H1: Patient evaluation is positively associated with 
patient compliance. 
 
3.2. Community Ratings Valence 
 
Kasl [36] argued for the need to extend HBM to the 
context of chronic healthcare patients. In addition to 
patients’ own beliefs about the treatment, previous 
studies have argued that other people’s opinions about 
treatments affect their behavior. For example, n the 
context of chronic healthcare patients, HBM has been 
extended to explain how mothers’ beliefs affect 
children’s compliance with treatment for diabetes 
[37]and asthma [38] patients. These studies provided 
the first steps in linking other people’s beliefs to 
patients’ compliance. The widespread use of Web 2.0. 
technologies has helped patients connect with others 
who have similar illnesses. Patients can discuss their 
opinions and experiences with different treatments 
with other community members. Now, patients’ beliefs 
and opinions about their treatments are also likely to be 
affected by the opinions of others who are not their 
immediate family. Therefore, patients who participate 
in health online communities are likely to be affected 
by other community members’ evaluations. 
Additionally, community members’ healthcare 
decisions may affect patients’ health-related behavior.  
H2: Community evaluation is positively associated 
with patient evaluation. 
H3: Community compliance is positively 
associated with patient compliance. 
 
3.3. Community Ratings Variance 
 
Ratings variance can potentially reveal additional 
information to the ratings valence. In the context of 
online product reviews, Sun [39] finds that average 
high valence is associated with high product quality, 
whereas high variance is associated with a niche 
product—one that is subject to polarized opinions. 
Therefore, the impact of ratings variance depends on 
ratings valence. Higher ratings variance on products is 
associated with higher product demand if the average 
ratings are low [39].  
In a healthcare context, where patients rate different 
treatments, if the ratings variance for treatment 
evaluations is high, it means that there is a lack of 
consensus among the patients regarding the perceived 
benefits of the treatments. This lack of consensus 
among the patients can be attributed to individual 
heterogeneity regarding the treatment or is a signal of 
treatment quality.  If the source of this discordance is 
the individual heterogeneity regarding the treatment, 
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then high variance could mean that the treatment’s 
effect varies greatly among different patients, meaning 
that it is a “niche” treatment. High ratings variance 
could also be a signal that the ratings are not 
trustworthy, therefore they can negatively affect 
patients’ evaluations. Therefore, we expect that ratings 
variance mitigates the effect of community ratings 
valence on treatment evaluation and compliance. 
H4: The positive relationship between community 
evaluation and patient evaluation is negatively 
moderated (weaker) when community evaluation 
variance is high. 
H5: The positive relationship between community 
compliance and patient compliance is negatively 
moderated (weaker) when community compliance 
variance is high. 
 
 
3.4. Community Size 
 
Consumer product ratings are subject to social 
influence from other consumers’ product ratings [40]. 
Ratings volume (the number of ratings) affects the 
effect of ratings valence on consumer decision making 
such that high ratings volume accentuates the 
perception of positivity in ratings[41]. In the context of 
an online health community, we hypothesize that 
community size is a moderator between community 
evaluation (or compliance) and patient evaluation (or 
compliance). The intuition is that the larger the size of 
the community, more credible is the signal that it 
provides [42]. High ratings volume increase the 
preference for a product that has positive valence while 
decreasing the preference for a product with negative 
valence [41], [43].  
H6: The interaction between community evaluation 
and community size is positively associated with 
patient evaluation. 
H7: The interaction between community 
compliance and community size is positively 
associated with patient evaluation. 
Figure 1 shows the research model and the 
proposed associations among the constructs.  
 
 
Figure 1. Research model 
 
4. Methodology  
 
4.1. Data Collection and Description 
 
We collected data from a public prominent online 
health community. This community counts over 
500,000 members who have over 2,500 different 
chronic health conditions. Patients can become 
members of the community and create a personal page 
on the community website where they can report their 
illnesses, treatments and progress. Moreover, 
community members and website visitors can browse 
all the treatments reported by all the patients in the 
community and view the reported treatment 
evaluations. Treatments are categorized into groups. 
Examples include prescription drugs, supplements, 
equipment and lifestyle modifications. 
We collected data using a Java-based web crawler. 
The crawler retrieved information about patients’ 
evaluations for 271 treatments. A total number of 
21,269 patients evaluated the treatments in our dataset. 
32% of the patients have only one treatment 
evaluation, while the rest have evaluated more than one 
treatment. Each patient evaluates one treatment only 
once. The patients evaluated the perceived treatment 
effectiveness, the treatment side effects, difficulty of 
taking the treatment as prescribed and treatment 
compliance. Additionally, each patient also reported 
the treatment start date. Table 1 shows the questions 
and scales used to measure the variables for treatment 
evaluation and treatment compliance. The questions 
and scales used to measure treatment evaluations are 
developed by the community website and presented to 
each patient when they decide to report a treatment 
evaluation. 
 
Table 1. Variable description 
Variable 
name 
Variable description 
Effectiveness 
Measures perceived treatment 
effectiveness on a scale 1-5 using the 
question “Currently, how effective is this 
treatment?” 
Side Effects 
Measures treatment side effects on a 
scale 1-4 using the question “Currently, 
how are the overall side effects of this 
treatment?” 
Burden 
Measures treatment burden on a scale 
1-4 using the question “How difficult is it 
for you to take this treatment as 
prescribed?” 
Patient 
Compliance 
Measures treatment compliance on a 
scale 1-4 using the question “Currently, 
how often do you take the treatment as 
prescribed?” 
Patient 
Evaluation 
The average of treatment effectiveness, 
treatment side effects (reverse coded) 
and treatment burden (reverse coded). 
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Table 1. Variable description (continued) 
Community 
Evaluation 
The average of patient evaluation for all 
the patients who have evaluated the 
treatment before the patient. 
Community 
Compliance 
The average of patient compliance for 
all the patients who have reported the 
treatment compliance before the 
patient. 
Community 
Evaluation 
Variance 
The standard deviation of patient 
evaluation for all the patients who have 
evaluated the treatment before the 
patient. 
Community 
Compliance 
Variance 
The standard deviation of patient 
compliance for all the patients who 
have reported the treatment 
compliance before the patient. 
Community 
Size 
The number of patients who have 
evaluated the treatment before the 
patient. 
Treatment 
Category 
1=Prescription Drug, 2=Other (e.g., 
over the counter, supplements, diet, 
exercise) 
Treatment 
Duration 
The difference between treatment start 
date and treatment evaluation date 
(days) 
 
. Measures: We calculated the patient treatment 
evaluation by averaging treatment effectiveness, 
treatment side effects (reverse coded) and treatment 
burden (reverse coded). We calculated community 
treatment evaluation for a patient as the average 
evaluation of all the patients who evaluated a treatment 
before the patient evaluation. Similarly, we calculated 
community compliance as the average compliance of 
all the patients who have reported their compliance 
before the patient. Community size is calculated as the 
total number of patients who have evaluated a 
treatment. See table 2 for descriptive statistics and 
table 3 for correlations of the variables used in the 
model. 
 
Table 2: Descriptive Statistics 
Variable Mean Std. dev. Min Max 
Patient Evaluation 3.391 0.708 1 4.333 
Community 
Evaluation 3.379 0.277 1 4.333 
Patient 
Compliance 3.548 0.817 1 4 
Community 
Compliance 3.576 0.214 1 4 
Community 
Evaluation 
Variance 0.173 0.107 0 1.061 
Community 
Compliance 
Variance 0.743 0.158 0 1.730 
Community Size 329.486 323.345 2 1843 
Treatment 
Category 1.197 0.397 1 2 
Treatment 
Duration 
1190.81
6 1851.807 0 18150 
N=41,368 
Table 3: Correlations 
  Variable 1 2 3 4 5 6 7 8 
1 
Patient 
Evaluation 
1.00
0        
2 
Community 
Evaluation 
0.30
7 
1.0
00       
3 
Patient 
Compliance 
0.19
4 
(0.
04
4) 
1.000 
     
4 
Community 
Compliance 
(0.06
1) 
(0.
17
7) 
0.193 
1.00
0     
5 
Community 
Evaluation 
Variance 
(0.05
9) 
(0.
16
0) 
0.010 
0.03
1 
1.00
0    
6 
Community 
Compliance 
Variance 
0.03
6 
0.0
53 
(0.132) 
(0.7
40) 
(0.0
61) 
1.00
0   
7 
Community 
Size 
0.02
6 
(0.
06
5) 
0.031 
0.15
1 
(0.4
00) 
(0.0
51) 
1.0
00  
8 
Treatment 
Category 
0.06
5 
0.2
35 
(0.116) 
(0.4
34) 
(0.0
88) 
0.22
4 
(0.
24
5) 
1.
00
0 
9 
Treatment 
Duration (ln) 
0.14
6 
0.0
83 
(0.007) 
(0.0
37) 
(0.0
66) 
0.02
6 
0.0
98 
0.
01
1 
N = 41,638 
 
5. Results  
 
Table 4 summarizes the results of a fixed effects 
regression model [44] for the effects of community 
variables on treatment evaluation and compliance with 
individual and time fixed effects.  
We find that the coefficient of Patient Evaluation in 
column 4 is 0.231 and significant at p< 0.01, 
suggesting that Patient Evaluation is positively 
associated with Compliance. This provides support for 
hypothesis H1. We also find that the coefficient of 
Community Evaluation in column 2 is 0.757 and 
significant at p< 0.01, suggesting that Community 
Evaluation is positively associated with Patient 
Evaluation. This provides support for hypothesis H2. 
We find a significant interaction of Community 
Evaluation and the Community Evaluation Variance 
(coefficient=-0.459, p< 0.01. This suggests that when 
Community Evaluation is low, higher variance is 
associated with higher Patient Evaluation. Also, when 
Community Evaluation is high, higher variance is 
associated with lower Patient Evaluation. This provides 
support for hypothesis H4. We also find a significant 
interaction of Community Evaluation and Community 
Size (coefficient=0.0002, p< 0.01. This suggests that 
when Community Evaluation is low, higher 
Community Size is associated with lower Patient 
Evaluation. Also, when Community Evaluation is high, 
higher Community Size is associated with higher 
Patient Evaluation. Table 4 summarizes the results of a 
fixed effects regression model [44] for the effects of 
community variables on treatment evaluation and 
compliance with individual and time fixed effects.  
We find that the coefficient of Patient Evaluation in 
column 4 is 0.231 and significant at p< 0.01, 
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suggesting that Patient Evaluation is positively 
associated with Compliance. This provides support for 
hypothesis H1. We also find that the coefficient of 
Community Evaluation in column 2 is 0.757 and 
significant at p< 0.01, suggesting that Community 
Evaluation is positively associated with Patient 
Evaluation. This provides support for hypothesis H2. 
We find a significant interaction of Community 
Evaluation and the Community Evaluation Variance 
(coefficient=-0.459, p< 0.01. This suggests that when 
Community Evaluation is low, higher variance is 
associated with higher Patient Evaluation. Also, when 
Community Evaluation is high, higher variance is 
associated with lower Patient Evaluation. This provides 
support for hypothesis H4. We also find a significant 
interaction of Community Evaluation and Community 
Size (coefficient=0.0002, p< 0.01. This suggests that 
when Community Evaluation is low, higher 
Community Size is associated with lower Patient 
Evaluation. Also, when Community Evaluation is high, 
higher Community Size is associated with higher 
Patient Evaluation. This provides support for 
hypothesis H6.  
We also find support for Hypothesis H3 because 
the coefficient of Community Compliance in column 4 
is 0.915 and significant at p< 0.01, suggesting that 
Community Compliance is positively associated with 
Patient Compliance. We find a significant interaction 
of Community Compliance and Community 
Compliance Variance (coefficient=-0.302, p< 0.01. 
This suggests that when Community Compliance is 
low, higher variance is associated with higher 
Compliance. Also, when Community Compliance is 
high, higher variance is associated with higher 
Compliance. This provides support for hypothesis H5. 
We also find a significant interaction of Community 
Compliance and Community Size (coefficient=0.0005, 
p< 0.01. This suggests that when Community 
Compliance is low, higher Community Size is 
associated with lower Compliance. Also, when 
Community Compliance is high, higher Community 
Size is associated with higher Compliance. This 
provides support for hypothesis H7.  
Overall, the results show that in larger 
communities, community evaluation and patient 
evaluation are positively associated more strongly than 
in smaller communities. Also, when evaluations have 
larger variance, community evaluation is associated 
less strongly with patient evaluation than when 
evaluations have smaller variance. 
 
 
 
 
Table 4: Estimation Results- The Effect of 
Online Community on Treatment evaluation 
and Compliance 
 (1) (2) (3) (4) 
VARIABLES DV: Patient 
Evaluation 
Main 
Effects 
DV: Patient 
Evaluation 
Full Model 
DV: Patient 
Compliance 
Main 
Effects 
DV: Patient 
Compliance 
Full Model 
Community 
Evaluation 0.719*** 0.757***   
 (0.0199) (0.0425)   
Community 
Evaluation 
Variance 0.123*** 1.700***   
 (0.0440) (0.481)   
Community 
Size -0.0007169 
-
0.000717*** 4.49e-05** -0.00192*** 
 (0.0002407) (0.000241) (1.95e-05) (0.000333) 
Patient 
Evaluation   0.229*** 0.231*** 
   (0.00969) (0.00967) 
Community 
Compliance 
Variance   0.142*** 1.290*** 
   (0.0479) (0.457) 
Community 
Compliance   0.743*** 0.915*** 
   (0.0419) (0.117) 
Community 
Evaluation* 
Community 
Evaluation 
Variance  -0.459***   
  (0.137)   
Community 
Evaluation* 
Community 
Size  0.000219***   
  (0.0000702)   
Community 
Compliance 
Variance * 
Community 
Compliance    -0.302** 
    (0.121) 
Community 
Size* 
Community 
Compliance    0.000544*** 
    (9.15e-05) 
Treatment 
Category -0.0127 -0.0116 -0.0806*** -0.0786*** 
 (0.0120) (0.0120) (0.0155) (0.0154) 
Treatment 
Duration (ln) 0.0517*** 0.0515*** -0.0185*** -0.0181*** 
 (0.00276) (0.00275) (0.00306) (0.00305) 
     
Constant 0.604*** 0.391** 0.121 -0.550 
 (0.136) (0.196) (0.244) (0.477) 
Time Fixed 
Effects Yes Yes Yes Yes 
Individual 
Fixed Effects Yes Yes Yes Yes 
Observations 41,638 41,638 41,638 41,638 
R-squared 0.119 0.121 0.082 0.084 
Number of 
patients 21,269 21,269 21,269 21,269 
Robust standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
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6. Discussion and Conclusion  
 
In this study, we examined the effects of online 
ratings for treatment evaluations in an online health 
community on treatment evaluations and treatment 
compliance for patients with chronic health conditions. 
The results of the study show that community ratings 
for treatments are positively associated with patient 
treatment evaluation and compliance. These effects are 
moderated by community size and online ratings 
variance. In larger communities, the association 
between online community ratings and patient 
evaluations and compliance is amplified. Also, when 
the ratings variance is high, the association between 
online community ratings and patient evaluations and 
compliance is weaker. 
This study contributes to the broader literature on 
the effects of IT on healthcare [45] by providing an 
empirical assessment of the effects of online treatment 
ratings for chronic health patients. Also, the study 
contributes to the emerging literature on online health 
communities [3], [29]by focusing on a large 
community of patients with different types of chronic 
health conditions. The results of this study also bear 
important implications for patients, healthcare 
practitioners and online health community designers. 
Based on our results, patients might consider “niche” 
treatments with higher treatment ratings variance if 
they are suffering from conditions that are difficult to 
diagnose. This study also emphasizes the role of 
patients as active decision makers regarding their 
health behavior, departing from traditional compliance 
literature that generally assumes the patient is a passive 
recipient of instructions from their doctor [7]. 
Nevertheless, healthcare providers might gain insights 
from the online community and recommend treatments 
that are rated low on average but have a high ratings 
variance to “zebra” patients, who have rare conditions.  
This study has several limitations. First, the data 
used is observational, and it is possible that the results 
reflect homophilic tendencies among community 
members in addition to social influence [46]. In order 
to address this shortcoming, the study could be 
enhanced by conducting a randomized experiment 
where patients are asked to evaluate different 
treatments but only a subsample of them receives 
information about the evaluations of other community 
members. Second, the treatment evaluation data is self-
reported by the patients. There have been concerns 
about the accuracy of patient self-reported health data 
as patients may report information that is not truthful 
[47]. However, the data for this study comes from a 
prominent online health community and the issue of 
falsely reported data is at odds with the longevity and 
size of the online community. Finally, there are 
relatively few seniors (age 75+) in the online 
community, which is not a representation of the 
general population. These limitations notwithstanding, 
we believe that study represents an important first step 
in understanding for technology mechanisms such as 
online social communities play a key role in shaping 
behavior of patients towards better compliance for 
treatment of chronic conditions. 
To conclude, participation in an online health 
community has important implications on treatment 
evaluations for community members. Future research 
might further investigate how the network position 
(e.g., betweenness, centrality) affects patients’ 
perceptions about the treatment. Another promising 
extension is related to the objectives of patients’ 
activities in the online community. For example, 
patients may join online health communities to 
socialize with other patients, to look for relevant 
information about their disease, or to simply keep a 
diary of symptoms and treatments for their own use. 
Understanding how the patients’ objectives affect their 
online activities, and subsequently their perceptions 
about their treatment will help online health 
communities customize their website to better meet 
patients’ requirements. Although these important 
questions are difficult to address in this study’s setting, 
future studies can conduct behavioral experiments 
which will provide valuable data to answer these 
questions.  
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